Published in Hepatitis Weekly, January 27th, 2003
Those findings, published in the journal Gut were reported by doctors at the Hotel-Dieu of Lyon, France.
"A proportion of liver transplanted patients with recurrent chronic hepatitis have a sustained virological response to combination therapy with interferon plus ribavirin. However, the long term benefit of antiviral therapy with regard to HCV RNA clearance remains unknown in patients with HCV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.